Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026)

Alkermes (ALKS) reported Other Non-Current Liabilities of $68.0 million for Q1 2026, up 15.63% year-over-year from $58.9 million in Q1 2025, and up 11.54% quarter-over-quarter from $61.0 million in Q4 2025.

Alkermes (ALKS) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Other Non-Current Liabilities data on file, last reported at $68.0 million in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $68.0 million, up 15.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.0 million (up 15.63% YoY), and the FY2025 annual result was $61.0 million, up 8.91% from the prior year.
  • Other Non-Current Liabilities improved to $68.0 million in Q1 2026 per ALKS's latest filing, from $61.0 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $68.0 million in Q1 2026 and troughed at $42.4 million in Q4 2022.
  • A 5-year average of $51.8 million and a median of $49.9 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • On a YoY basis, Other Non-Current Liabilities climbed as much as 33.43% in 2022 and fell as far as 2.9% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $42.4 million in 2022, then increased by 17.68% to $49.9 million in 2023, then increased by 12.31% to $56.0 million in 2024, then increased by 8.91% to $61.0 million in 2025, then gained by 11.54% to $68.0 million in 2026.
  • Business Quant data shows ALKS's Other Non-Current Liabilities at $68.0 million in Q1 2026, $61.0 million in Q4 2025, and $56.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.05 Mn
Dec 31, 2025 61.01 Mn
Sep 30, 2025 56.75 Mn
Jun 30, 2025 56.05 Mn
Mar 31, 2025 58.85 Mn
Dec 31, 2024 56.02 Mn
Sep 30, 2024 52.63 Mn
Jun 30, 2024 48.29 Mn
Mar 31, 2024 48.96 Mn
Dec 31, 2023 49.88 Mn
Sep 30, 2023 53.62 Mn
Jun 30, 2023 48.22 Mn
Mar 31, 2023 48.49 Mn
Dec 31, 2022 42.38 Mn
Sep 30, 2022 42.86 Mn
Jun 30, 2022 45.21 Mn
Mar 31, 2022 43.91 Mn
Dec 31, 2021 43.65 Mn
Sep 30, 2021 32.12 Mn
Jun 30, 2021 36.32 Mn